The aim of the paper was to examine the correlation between the total risk of cardiovascular events, determined by the SCORE (Systematic Coronary Risk Evaluation) system, and bone density in postmenopausal women. Examinees and method: The research involved 300 postmenopausal women. On the basis of bone density measurements, the participants were divided into three groups: group I -84 examinees had osteoporosis, group II -115 examinees had osteopenia, and group III -101 examinees had normal bone mineral density (BMD ). Multivariate logistic regression analysis showed that the following factors caused a significant increase in the risk of decreasing BMD: every year of life by 20%, menopause duration by 26%, increase in systolic blood pressure (BP) by 1 mm Hg by 7%, increase in SCORE risk by 1% by 5.31 times, physical inactivity by 5.96 times, and osteoporosis in the family history by 3.91 times. Conclusion: Postmenopausal women who are at high risk for cardiovascular diseases have a lower BMD than those who are not at high risk for cardiovascular diseases. © Versita Sp. z o.o.
Introduction
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality in the majority of the European population [1] .
Cardiovascular diseases are strongly influenced by lifestyle and have numerous risk factors. A large number of clinical trials have demonstrated that the modification of risk factors (regulation of blood pressure, smoking cessation, increased physical activity, obesity reduction) as well as prophylactic therapy reduces the cardiovascular morbidity and mortality, especially in high-risk patients [2] [3] [4] .
European recommendations for the prevention of cardiovascular diseases in clinical practice from 2003 suggest a model for the estimation of total risk of cardiovascular diseases, based on the SCORE (Systemic Coronary Risk Evaluation) system. The SCORE system predicts any kind of fatal cardiovascular event over a 10 -year period, taking into account the following risk factors: gender, age, smoking, systolic blood pressure, and total cholesterol or the cholesterol/HDL-C ratio [5, 6] .
Osteoporosis (OP) is the most frequent metabolic bone disease characterized by impaired bone strength, microstructural disorders leading to increased bone fragility, and risk of fracture. Bone strength is determined by two basic features: bone mineral density (BMD) and bone quality [7, 8] . Bone mass is affected by many factors, such as genetics, physical activity, nutrition, muscle strength, smoking and hormonal status [9] .
The prevalence of CVDs and OP increases with aging; the diseases are influenced by numerous common pathophysiological mechanisms. Age, dyslipidemia, oxidative stress, inflammation, hypertension, hyperhomocysteinemia, diabetes, and lifestyle factors are associated with increased risk of lower bone density and cardiovascular diseases [10] .
Conceptually, cardiovascular diseases and osteoporosis are connected by common factors affecting equally both vascular and bone cells. Artery calcification is common in atherosclerosis and is associated with a higher risk for a cardiovascular event. Vascular calcification is similar to bone formation, and both are regulated by estrogen. Oxidized serum lipids, besides having an already determined role in atherogenesis, affect both osteoblasts and osteoclasts in experimental conditions. Numerous cellular and molecular elements, such as type I collagen, osteonectin, osteopontin, osteoprotegerin, and oxidized lipids, appear to regulate the process of mineralization in bones as well as in vasculature, which can account for the coexistence of osteoporosis and atherosclerotic calcification, independent of age. Calcification of vascular cells is associated with osteoblast differentiation [11] [12] [13] .
Aim
The aim of the paper was to examine the correlation between the total risk of cardiovascular events, determined by the SCORE system, and bone density in postmenopausal women.
Examinees
The research involved 300 women referred for densitometric examination as they belonged to the risk group of postmenopausal women; the examination was undertaken in the Bone Densitometry Unit in the Institute for Treatment and Rehabilitation "Niška Banja", Niš. All the participants were in the postmenopausal period (menopause is defined as the condition of an absence of menstrual periods for 12 months). The research excluded those with documented cardiovascular disease, diabetes, secondary osteoporosis caused by endocrine disorders, systemic diseases, as well as those who took drugs known to influence bone metabolism (glucocorticoids and anticonvulsants).
Characteristics of examined groups
Based on bone density measurements, the examinees were divided into three groups:
Group I -84 examinees had osteoporosis, i.e., T score ≤ -2.5 SD;
Group II -115 examinees had osteopenia, i.e., T score from -1 to -2.5 SD;
Group III -101 examinees had normal bone density, with the T score ≥ -1 SD.
In the research, the following parameters were used: 1. Clinical patient processing included taking a personal history, as prescribed by the protocol. 2. Densitometry determination of bone density. Bone density measurements were made in the lumbar spine by DXA Densitometer Choplogic Discovery QDR-C, and the results were presented as absolute values (g/cm 2 ) and T score. According to the recommendations of the World Health Organization (WHO), the gold standard for bone density measurement is a dual energy x-ray absorptiometry (DEXA) scan that measures bone density in the spine and left hip [8] . According to the WHO definition, normal bone mineral density is present when the T score is -1.0 or above; in osteopenia, the T score is between -1 and -2.5; in osteoporosis, the T-score is 2.5 standard deviations (SD) below the mean for the young, healthy female population. Severe osteoporosis, with a T score ≤ -2.5 SD, is accompanied by fractures [14] . 3. Anthropometric measurement included the measurements of body mass (BM) and body height (BH). Based on these measurements, the body mass index (BMI) was calculated according to the following formula:
BMI (kg/m 2 ) = BM (kg)/BH 2 (m 2 ) Obesity was defined as BMI>30 kg/m 2 . Waist circumference was measured by positioning a measuring tape halfway between the top of the hip bone and the bottom of the rib cage, and the values were estimated according to the WHO criteria. Normal value for women is <88 cm. 4. Arterial blood pressure (BP) measurement was performed with the examinee in the sitting position, half an hour after rest, on both arms, by the auscultatory Korotkoff technique, using a sphygmomanometer. The highest mean value of three measurements performed on one arm was used for further statistical calculations. 5. Lifestyle, in the sense of physical activity, smoking and alcohol use, was analyzed. The examinees who reported being physically active (fast walking, bicycling, swimming, doing aerobic exercises) for 30-45 minutes 4-6 times a week were regarded as physically active; this intensity amounted to 60-75% of the corresponding heart frequency [15] . Smokers were defined as individuals who reportedsmoking daily. Non-smokers included ex-smokers (who did not smoke for more than two years) and the individuals who had never smoked.
Biochemical parameters
The following biochemical values were determined: total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, glycemia, serum calcium and phosphorus.
• Total cholesterol (TC) was determined by enzymatic colorimetric method (PAP); reference laboratory values -3.9-5.5 mmol/l.
• Triglycerides (TG) were determined by enzymatic colorimetric method; reference laboratory values -0.70-2.0 mmol/l.
• HDL cholesterol (HDL-C) was determined by enzymatic colorimetric method (PAP); reference laboratory values -1.0-1.7 mmol/l for women.
• LDL cholesterol (LDL-C) was indirectly determined, using the following formula: LDL-C=Hol -Tg/2.2-HDL-C; reference laboratory values -2.8-3.9 mmol/l.
• Glucose (Gly) was determined by GOD-PAP method; reference laboratory values -3.6-6.1 mmol/l.
• Serum Ca was determined by spectrophotometric method; reference laboratory values -2.20-2.65 mmol/l.
• Serum phosphorus (P) was determined by spectrophotometric method; reference laboratory values -0.81-1.45 mmol/l.
Determination of the total 10-year risk for the occurrence of fatal cardiovascular event.
The SCORE system offers two charts for the estimation of a 10-year risk of fatal cardiovascular events. The low-risk chart is used in Belgium, France, Greece, Italy, Luxembourg, Spain, Switzerland and Portugal, while the high risk chart is used in all other countries of Europe [6] . The total10-year risk was calculated for all examinees with the SCORE system charts for the countries with high cardiovascular risk.
In our research, the examinees with a risk for fatal cardiovascular events ranging from 0 % to 4% were classified in the low-risk group, while the examinees with the risk ≥ 5% were classified in the high-risk group.
Statistical methods
Quantitative statistical analysis was performed on a PC, with Microsoft Office Excel 2003 Software used for registration, rating, grouping, and tabular and graphical data presentation and SPSS 10.0 for calculations.
The following statistical parameters were presented: arithmetic mean (Xsr), standard deviation (SD), minimum and maximum values, structure index (%), and a 95% confidence interval (95% CI).
To compare the means of the two groups of examinees, when the distribution of values did not meet the requirements of normal distribution, the Student's t-test and Mann-Whitney U test were used. Values among the three groups of examinees were compared using a simple univariate analysis of variance (ANOVA with Dunnett post hoc test).
To compare the frequency of certain features when some of the expected frequencies were below 5, MantelHaenszel Chi-square test and Fisher's exact probability test were used.
An estimate of the influence of the factors of interest on the values on bone density was performed with linear regression analysis. Regression coefficients (B) and their 95% confidence intervals were calculated. Statistical significance of regression coefficients was checked with the t-test. The factors proved by univariate regression to significantly influence the values of dependent variables were included in the multivariate regression models. Application of the backwards stepwise method excluded the factors that were not statistically significant in a multivariate analysis. The values of coefficients represented the changes in the values of dependent variables caused by the changes in the values of independent variables by one measuring unit. For independent variables, the regression coefficient represented a change in the value of dependent variable in one modality compared to another one.
An estimate of significant predictors of osteopenia and osteoporosis was obtained by logistic regression analysis. We calculated the values of approximate risk (odds ratio -OR) for the occurrence of osteopenia and osteoporosis as influenced by the score factors for total cardiovascular risk, as well as traditional risk factors for cardiovascular diseases. Statistical significance of the calculated OR values was checked by the Wald test based on the chi square distribution. After univariate regression analysis, the multivariate analysis was performed according to the same principles as the linear regression analysis.
In all analyses, an error estimate lower than 5% (p<0.05) was taken as the borderline statistical significance. The results of statistical analysis are presented in tables and graphs.
Results
The participants with a high total risk for cardiovascular events were statistically significantly older compared to women at low risk with a longer menopause duration and had significantly lower bone density and T score values. All components of the SCORE system, as well as traditional risk factors for the occurrence of cardiovascular events (physical inactivity, hypertension, hyperlipidemia), were significantly reported more often in the examinees with high total risk. Women with a high total risk of cardiovascular events had a significantly increased documented family history for cardiovascular (CV) diseases and osteoporosis and a significantly smaller number of childbirths than the examinees with lower CV risk.
The levels of glycemia, calcium, and phosphorus, as well as alcohol consumption, did not significantly differ among women with different levels of risk for CV diseases (Table 1) .
Univariate linear regression analysis showed a significant negative correlation between age and menopause duration and between age and bone density as follows: age by 0.012 g/cm 2 2 ). The presence of CVD in the family history was associated with a decrease in bone density by 0.113 g/cm 2 (0.086-0.140), and osteoporosis in the family history showed a decrease in bone density by 0.084 (0.084-0.120).
HDL level showed a significant positive correlation with bone density by 0.057 g/cm 2 (0.005-0.109); the participants who had experienced childbirth had an increase in bone density by 0.078 g/cm 2 (0.020-0.136 g/ cm 2 ) compared to women who had not. BMI, glycemia, level of phosphorus, and alcohol consumption did not significantly influence bone density values ( Table 2 ).
An increase in the total cardiovascular risk by 1% caused a decrease in bone density by 0.033 g/cm 2 (0.029-0.036 g/cm 2 ) (Graph 1). Multivariate logistic regression analysis indicated age, menopause duration, SBP, total cardiovascular risk, physical inactivity, and osteoporosis in the family history as stastistically significant factors for the change of risk of osteopenia and osteoporosis. All these factors caused a significant increase in the risk of a bone density decrease in the examinees as follows: every year of life by 20% (7-32%), menopause duration by 26% (8-47%), increse in SBP by 1 mm Hg by 7% (1-13%), increase in total cardiovascular risk by 1 by 5.31 times, (2.18-12.94 times), physical inactivity by 5.96 times (1.03-34.60 times), osteoporosis in the family history by 3.91 times (1.14-13.42 times). Every year of hypertension increased the risk of osteopenia and osteoporosis by 34%; the estimation error for this claim was below 10% (p<0.1) ( Table 3 , Graph 2).
Multivariate logistic regression analysis was performed separately for the group with osteopenia and the group with osteoporosis, and with osteopenia and osteoporosis as statistically significant factors for an increase in the risk of lowered BMD, the analysis confirmed the total cardiovascular risk. Increase in the total cardiovascular risk by 1% correlated with a decrease in the bone density by 4.11 times, p<0,001 (2,03 A multivariate model, which included as independent variables the aforementioned factors, accounted for a 77.5% change in the risk of osteopenia and osteoporosis in the women (R 2 =0.775).
Discussion
Recent research and numerous observations related both to pathogenicity and therapeutic interventions point to a possible essential relationship between osteoporosis and atherosclerosis. [10, 16, 17] . Many studies have demonstrated that female gender, old age, and early menopause are important invariable risk factors for the occurrence of osteoporosis. The authors of research conducted in Japan, which included 1.035 women aged 40-70 years in the postmenopausal period, concluded that women with late menopause (early menopause <49 years of age) were at decreased risk of low bone mineral density by 0.69 (0.49-0.94). Postmenopausal women with a longer reproductive period (menopause >50 years) were also at decreased risk of low bone mineral density. In a multivariate analysis, early menopause and a short reproductive period were independent predictors for development of lower bone mineral density and osteoporosis [18] .
The latest research has demonstrated that renin-angiotensisn system (RAS) plays a key role in blood pressure control and influences bone density. Investigations by Asaba et al. undertaken on transgenic RAS mice pointed to the role of angiotensin II in the occurence of osteoporosis. Angiotensin II, over cytokines, receptor activator of nuclear factor κβ (RANK) ligands and vascular endothelial hormon growth (VEHG), stimulates the osteoclast formation, thereby decreasing the bone density. They concluded that the application of drugs that inhibit the synthesis of angiotensin (angiotensin--converting enzyme) inhibitors can be effective in the treatment of hypertension and osteoporosis [19] .
Numerous studies have yielded conflicting results regarding the relationship between lipid profile and bone density. A number of authors have confirmed a strong connection between lipid profile and bone mass; however, there have been some reports that changes in lipid status do not significantly correlate with bone mass [20] [21] [22] .
Solomon et al. included in their research 13,592 individuals from the NHANES study (The National Health and Nutritional Examination Survey) to compare bone density and lipid levels; the survey excluded persons who were receiving lipid-lowering therapy. The data of this large survey demonstrate that elevated levels of total cholesterol and LDL cholesterol were associated with decreased bone density, while high values of HDL Graph 2. Values of OR and their 95% CI for the estimation of significant factors' influence on bone density -results of multivariate logistic regression analysis cholesterol were associated with increased bone density values [23] .
Lifestyle is a significant risk factor for the occurrence of CV diseases and osteoporosis. Regular physical activity is equally effective in the prevention of cardiovascular diseases, osteoporosis, and various other chronic diseases including obesity, hypertension, type 2 diabetes, colon and breast cancer, as well as psychosomatic diseases [24] .
Smoking causes early menopause, thereby leading to hypoestrogenemia, increases in the levels of catecholamines and markers of inflammation, and decreases in the HDL cholesterol levels, thus exerting a toxic effect on the bone tissue [24, 25] .
Research has also shown that bone mass decrease significantly increases the mortality from cardiovascular diseases in postmenopausal women. Tanko et al., who for 4 years followed 2,576 postmenopusal women without evidence of cardiovascular disease, showed that postmenopausal women with osteoporosis have a risk of adverse cardiovascular events 3.9 times greater than women of the same age with osteopenia, who have a risk of cardiovascular events 2.1 times greater than women with normal bone mass [26] .
Kadu et al. in their research proved that a decrease in BMD by one standard deviation increases the risk of mortality from ischemic heart disease or other forms of atherosclerosis by 1.2 -1.3 times [27] .
Von Der Recke et al. demonstrated that the lowest bone mass in women in their study was associated with a two-fold increased risk of adverse cardiovascular events compared to women with the highest bone mass [28] .
The analysis of a 10-year risk of fatal cardiovascular event in our examinees showed that it is statistically significantly higher in osteoporotic women (p<0.001) compared to women with osteopenia and normal bone density. An increase in total cardiovascular risk by 1% caused a decrease in bone density of 0.033 g/cm 2 (0.029-0.036) g/cm 2 ). In a multivariate logistic regression analysis, the increase of total cardiovascular risk by 1% further increased the risk of low BMD by 5.31 times.
Low bone mineral density can independently predict the risk of cardiovascular disease and cardiovascular mortality in postmenopausal women. The calculation of cardiovascular risk can be used for identification of individuals with low BMD. Magnus et al., in a group of 3,881 female and male examinees without a history of cardiovascular disease and cerebrovascular insult, investigated the relationship between BMD and a 10-year cardiovascular risk calculated by the Framingham model. A group of women who had a 20% cardiovascular risk were 73% more likely to have low BMD [29] .
Marcovitz et al., who compared coronary angiography and bone density, confirmed that low bone density is an independent predictor of coronary disease. Bone density was determined in the lumbar spine by DEXA densitometry. Significant stenosis of the coronary arteries was found in 62% of women with osteopenia and 75% of women with osteoporosis [30] .
The results of our research demonstrate that the detemination of total cardiovascular risk can be very useful for the selection of women in whom densitometry should be performed for early detection of osteopenia and osteoporosis.
Limitations
Because of the small study size (only 300 patients), the conclusion should be drawn with caution. The research should be continued with the inclusion of male patients, and the conclusive importance of the results will be demonstrated after follow-up of the examinees.
Conclusion
Osteoporosis and atherosclerosis both greatly influence the health of the aging population and postmenopausal women. Both chronic diseases have similar risk factors (physical inactivity, smoking, age profile, lipid status, alcohol consumption). Risk factors for cardiovascular disease are more frequent in osteoporotic postmenopausal women, and low bone density is reported in postmenopausal women at high total risk of cardiovascular diseases. 
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